Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Parkinsonscongress-2018

Sessions/Tracks

Track 1: Parkinson ’s disease

Parkinson's sickness is a dynamic issue of the sensory system that influences development. It grows slowly, in some cases beginning with a scarcely detectable tremor in only one hand. However, while a tremor might be the most surely understood indication of Parkinson's infection, the turmoil likewise regularly causes solidness or moderating of development. In the early phases of Parkinson's illness, your face may indicate next to zero demeanour, or your arms may not swing when you walk. Your discourse may turn out to be delicate or slurred. Parkinson's malady indications compound as your condition advances after some time.

Related Conferences:Parkinson’s Congress | Parkinson’s Conferences | Parkinson’s Meetings | Neuroscience Conferences

7th Addiction Research Conference and Therapy, November 13-15, 2017 Las Vegas, USA; 5th Neurological Disorders Conference and Stroke Conference, November 13-14, 2017 London, UK; 10th Alzheimer’s Disease Congress and Dementia Congress, May 30-31, 2018 Osaka Japan; 11th Vascular Dementia Conference February 22-23, 2018 Paris, France;20th Neuroscience Conference and Neurochemistry Conference February 26-27, 2018 Berlin, Germany; Parkinson’s Disease Therapeutics Conference October 30, 2017 New York city USA; 13th International Conference on Alzheimer’s & Parkinson’s Disorders, March 29-April 2 2017 Vienna, Austria; 5th World Parkinson Congress, June 4-7 2019 Kyoto; Comprehensive Review of Movement Disorders for the Clinical Practitioner, August 1-4, 2017 Colorado USA;19th International Conference on Parkinson’s Disease & Movement Disorders May 25-26 2017 London UK;; International Parkinson & Movement Disorder Society,  Northwest Parkinson’s Foundation, American Neurological AssociationWorld Parkinson Coalition, American Parkinson’s Disease Association

Track 2: Epidemiology of Parkinson’s disease

Parkinson's sickness is one of the outstanding age related neurodegenerative issue, second in repeat just to Alzheimer's infection. Parkinson's malady likewise causes broad damage of the engine or tactile pathways stretching out past the pig mental cerebrum stem cores. In spite of the fact that the ailment side effects can be controlled by Levodopa yet the etiology of the Parkinson's illness stays cloud.

Related Conferences:  Parkinson’s Congress | Parkinson’s Conferences | Parkinson’s Meetings | Neuroscience Conferences

7th Addiction Research Conference and Therapy, November 13-15, 2017 Las Vegas, USA; 5th Neurological Disorders Conference and Stroke Conference, November 13-14, 2017 London, UK; 10th Alzheimer’s Disease Congress and Dementia Congress, May 30-31, 2018 Osaka Japan; 11th Vascular Dementia Conference February 22-23, 2018 Paris, France;20th Neuroscience Conference and Neurochemistry Conference February 26-27, 2018 Berlin, Germany; Parkinson’s Disease Therapeutics Conference October 30, 2017 New York city USA; 13th International Conference on Alzheimer’s & Parkinson’s Disorders, March 29-April 2 2017 Vienna, Austria; 5th World Parkinson Congress, June 4-7 2019 Kyoto; Comprehensive Review of Movement Disorders for the Clinical Practitioner, August 1-4, 2017 Colorado USA;19th International Conference on Parkinson’s Disease & Movement Disorders May 25-26 2017 London UK;; International Parkinson & Movement Disorder Society,  Northwest Parkinson’s Foundation, American Neurological AssociationWorld Parkinson Coalition, American Parkinson’s Disease Association

Track 3: Neuromuscular Disorders

Neuromuscular turmoil is an infection that influences the fringe sensory system which incorporates muscles, nerve-muscle intersection, and fringe nerves in the appendages and engine nerve cells in the spinal rope. Roughly 5600 individuals in the US are determined to have ALS every year. In US every year 750,000 individuals encounter stroke, 11000 individuals endure spinal line damage, 500,000 individuals experiencing cerebral paralysis, 270,000 with numerous sclerosis and 5.3 million with the after effects of horrendous mind damage and amyotrophic sidelong sclerosis.

Related Conferences: Parkinson’s Congress | Parkinson’s Conferences | Parkinson’s Meetings | Neuroscience Conferences

7th Addiction Research Conference and Therapy, November 13-15, 2017 Las Vegas, USA; 5th Neurological Disorders Conference and Stroke Conference, November 13-14, 2017 London, UK; 10th Alzheimer’s Disease Congress and Dementia Congress, May 30-31, 2018 Osaka Japan; 11th Vascular Dementia Conference February 22-23, 2018 Paris, France;20th Neuroscience Conference and Neurochemistry Conference February 26-27, 2018 Berlin, Germany; Parkinson’s Disease Therapeutics Conference October 30, 2017 New York city USA; 13th International Conference on Alzheimer’s & Parkinson’s Disorders, March 29-April 2 2017 Vienna, Austria; 5th World Parkinson Congress, June 4-7 2019 Kyoto; Comprehensive Review of Movement Disorders for the Clinical Practitioner, August 1-4, 2017 Colorado USA;19th International Conference on Parkinson’s Disease & Movement Disorders May 25-26 2017 London UK;; International Parkinson & Movement Disorder Society,  Northwest Parkinson’s Foundation, American Neurological AssociationWorld Parkinson Coalition, American Parkinson’s Disease Association

Track 4: Alzheimer's Disease & Dementia

Alzheimer's is caused by cerebrum cell demise. It is a neurological issue in which the demise of cerebrum cells causes memory misfortune and intellectual decrease. The aggregate size of the cerebrum contracts in Alzheimer's, nerve cells and associations in the tissue logically lessened, which can't be seen or tried in the living mind influenced by Alzheimer's ailment, posthumous/post-mortem examination will dependably demonstrate little incorporations in the nerve tissues, called as plaques and tangles. Plaques are found between the diminishing cells in the mind - from the development of a protein called beta (amyloid plaques). The tangles exist in the mind neurons, from a breaking down of second protein, called tau.

Around the world, with Dementia or Related issue almost 44 million individuals have endured in 2015,past outcomes demonstrated 35.66 million populace lived with dementia worldwide in year 2010, with numbers anticipated that would about twofold every twenty years, to 65.7 million out of 2030 and 115.4 million out of 2050. In 2010, fifty eight for each penny of all populace with dementia lived in nations with lower or direct livelihoods, with this extent expected to ascend to 63% till 2030 and 71% by 2050. This condition is expected to twofold by 2030 and very triple by 2050 to 115 million.

Related Conferences:  Parkinson’s Congress | Parkinson’s Conferences | Parkinson’s Meetings | Neuroscience Conferences

7th Addiction Research Conference and Therapy, November 13-15, 2017 Las Vegas, USA; 5th Neurological Disorders Conference and Stroke Conference, November 13-14, 2017 London, UK; 10th Alzheimer’s Disease Congress and Dementia Congress, May 30-31, 2018 Osaka Japan; 11th Vascular Dementia Conference February 22-23, 2018 Paris, France;20th Neuroscience Conference and Neurochemistry Conference February 26-27, 2018 Berlin, Germany; Parkinson’s Disease Therapeutics Conference October 30, 2017 New York city USA; 13th International Conference on Alzheimer’s & Parkinson’s Disorders, March 29-April 2 2017 Vienna, Austria; 5th World Parkinson Congress, June 4-7 2019 Kyoto; Comprehensive Review of Movement Disorders for the Clinical Practitioner, August 1-4, 2017 Colorado USA;19th International Conference on Parkinson’s Disease & Movement Disorders May 25-26 2017 London UK;; International Parkinson & Movement Disorder Society,  Northwest Parkinson’s Foundation, American Neurological AssociationWorld Parkinson Coalition, American Parkinson’s Disease Association

Track 5: Anxiety and Depression

A great many people feel on edge or discouraged now and again. Losing a friend or family member, landing terminated from a position, experiencing a separation, and other troublesome circumstances can lead a man to feel tragic, desolate, frightened, apprehensive, or restless. These sentiments are typical responses to life's stressors.

Be that as it may, a few people encounter these emotions day by day or almost day by day for no evident reason, making it hard to continue with ordinary, regular working. These individuals may have an uneasiness issue, dejection, or both.

It is normal for somebody with a tension issue to likewise experience the ill effects of gloom or the other way around. About one-portion of those determined to have despondency are likewise determined to have a tension issue. Fortunately these clutters are both treatable, independently and together.

Related Conferences:  Parkinson’s Congress | Parkinson’s Conferences | Parkinson’s Meetings | Neuroscience Conferences

7th Addiction Research Conference and Therapy, November 13-15, 2017 Las Vegas, USA; 5th Neurological Disorders Conference and Stroke Conference, November 13-14, 2017 London, UK; 10th Alzheimer’s Disease Congress and Dementia Congress, May 30-31, 2018 Osaka Japan; 11th Vascular Dementia Conference February 22-23, 2018 Paris, France;20th Neuroscience Conference and Neurochemistry Conference February 26-27, 2018 Berlin, Germany; Parkinson’s Disease Therapeutics Conference October 30, 2017 New York city USA; 13th International Conference on Alzheimer’s & Parkinson’s Disorders, March 29-April 2 2017 Vienna, Austria; 5th World Parkinson Congress, June 4-7 2019 Kyoto; Comprehensive Review of Movement Disorders for the Clinical Practitioner, August 1-4, 2017 Colorado USA;19th International Conference on Parkinson’s Disease & Movement Disorders May 25-26 2017 London UK;; International Parkinson & Movement Disorder Society,  Northwest Parkinson’s Foundation, American Neurological AssociationWorld Parkinson Coalition, American Parkinson’s Disease Association

Track 6: Neuropsychiatric Disorders

Uneasiness and consideration deficiency hyperactivity issue (ADHD), are among the most every now and again analyzed of every single neuropsychiatric issue. Albeit many individuals can be treated with ordinary solutions, these medications regularly have undesirable reactions and might be redirected for illegal utilize. Researchers have made imperative commitments to our comprehension of the organic premise and pharmacological administration of tension and ADHD, and extra examinations have given new bits of knowledge into the pathophysiology and treatment of self-damaging conduct (SIB).

Related Conferences:  Parkinson’s Congress | Parkinson’s Conferences | Parkinson’s Meetings | Neuroscience Conferences

7th Addiction Research Conference and Therapy, November 13-15, 2017 Las Vegas, USA; 5th Neurological Disorders Conference and Stroke Conference, November 13-14, 2017 London, UK; 10th Alzheimer’s Disease Congress and Dementia Congress, May 30-31, 2018 Osaka Japan; 11th Vascular Dementia Conference February 22-23, 2018 Paris, France;20th Neuroscience Conference and Neurochemistry Conference February 26-27, 2018 Berlin, Germany; Parkinson’s Disease Therapeutics Conference October 30, 2017 New York city USA; 13th International Conference on Alzheimer’s & Parkinson’s Disorders, March 29-April 2 2017 Vienna, Austria; 5th World Parkinson Congress, June 4-7 2019 Kyoto; Comprehensive Review of Movement Disorders for the Clinical Practitioner, August 1-4, 2017 Colorado USA;19th International Conference on Parkinson’s Disease & Movement Disorders May 25-26 2017 London UK;; International Parkinson & Movement Disorder Society,  Northwest Parkinson’s Foundation, American Neurological AssociationWorld Parkinson Coalition, American Parkinson’s Disease Association

Track 7: Diagnosis for Parkinson’s Disease

Making an exact analysis of Parkinson's — especially in its initial stages — is troublesome, yet a gifted professional can arrive at a contemplated conclusion that it is PD. You may have encountered this dissatisfaction. Maybe it took years for you to get a finding. Maybe you have been analysed, however with Parkinsonism, not Parkinson's, and are befuddled about the suggestions.

The bedside examination by a neurologist remains the first and most imperative demonstrative apparatus for patients associated with having PD. At the point when questions emerge, some more up to date imaging modalities, for example, PET and DAT sweeps may help determination, when performed by a specialist in neuroimaging. DAT scan is FDA-affirmed for separating PD from fundamental tremor, however it can't recognize PD and parkinsonian subtypes.

Related Conferences:  Parkinson’s Congress | Parkinson’s Conferences | Parkinson’s Meetings | Neuroscience Conferences

7th Addiction Research Conference and Therapy, November 13-15, 2017 Las Vegas, USA; 5th Neurological Disorders Conference and Stroke Conference, November 13-14, 2017 London, UK; 10th Alzheimer’s Disease Congress and Dementia Congress, May 30-31, 2018 Osaka Japan; 11th Vascular Dementia Conference February 22-23, 2018 Paris, France;20th Neuroscience Conference and Neurochemistry Conference February 26-27, 2018 Berlin, Germany; Parkinson’s Disease Therapeutics Conference October 30, 2017 New York city USA; 13th International Conference on Alzheimer’s & Parkinson’s Disorders, March 29-April 2 2017 Vienna, Austria; 5th World Parkinson Congress, June 4-7 2019 Kyoto; Comprehensive Review of Movement Disorders for the Clinical Practitioner, August 1-4, 2017 Colorado USA;19th International Conference on Parkinson’s Disease & Movement Disorders May 25-26 2017 London UK;; International Parkinson & Movement Disorder Society,  Northwest Parkinson’s Foundation, American Neurological AssociationWorld Parkinson Coalition, American Parkinson’s Disease Association

Track 8: Managing life with Parkinson’s  Disease

It is essential to develop a strong Parkinson’s disease administration design since Parkinson’s disease is an incessant sickness. Dealing with Parkinson’s malady incorporates building a human services group with appropriate specialists, legitimate admission of meds, activities, nourishment and rest.

Related Conferences:  Parkinson’s Congress | Parkinson’s Conferences | Parkinson’s Meeting | Neuroscience Conferences

7th Addiction Research Conference and Therapy, November 13-15, 2017 Las Vegas, USA; 5th Neurological Disorders Conference and Stroke Conference, November 13-14, 2017 London, UK; 10th Alzheimer’s Disease Congress and Dementia Congress, May 30-31, 2018 Osaka Japan; 11th Vascular Dementia Conference February 22-23, 2018 Paris, France;20th Neuroscience Conference and Neurochemistry Conference February 26-27, 2018 Berlin, Germany; Parkinson’s Disease Therapeutics Conference October 30, 2017 New York city USA; 13th International Conference on Alzheimer’s & Parkinson’s Disorders, March 29-April 2 2017 Vienna, Austria; 5th World Parkinson Congress, June 4-7 2019 Kyoto; Comprehensive Review of Movement Disorders for the Clinical Practitioner, August 1-4, 2017 Colorado USA;19th International Conference on Parkinson’s Disease & Movement Disorders May 25-26 2017 London UK;; International Parkinson & Movement Disorder Society,  Northwest Parkinson’s Foundation, American Neurological AssociationWorld Parkinson Coalition, American Parkinson’s Disease Association

Track 9: Neuroimaging

Neuroimaging or mind imaging is the utilization of different methods to either specifically or by implication picture the structure, work/pharmacology of the sensory system. It is a generally new train inside prescription, neuroscience, and psychology. Physicians who spend significant time in the execution and translation of neuroimaging in the clinical setting are Neuro Radiologists.

Neuroimaging falls into two general classifications:

Auxiliary imaging, which manages the structure of the sensory system and the analysis of gross (expansive scale) intracranial sickness, (for example, tumor) and damage. Practical imaging, which is utilized to analyse metabolic illnesses and sores on a better scale, (for example, Alzheimer's infection) and furthermore for neurological and intellectual brain science research and building cerebrum PC interfaces.

Related Conferences:  Parkinson’s Congress | Parkinson’s Conferences | Parkinson’s Meetings | Neuroscience Conferences

7th Addiction Research Conference and Therapy, November 13-15, 2017 Las Vegas, USA; 5th Neurological Disorders Conference and Stroke Conference, November 13-14, 2017 London, UK; 10th Alzheimer’s Disease Congress and Dementia Congress, May 30-31, 2018 Osaka Japan; 11th Vascular Dementia Conference February 22-23, 2018 Paris, France;20th Neuroscience Conference and Neurochemistry Conference February 26-27, 2018 Berlin, Germany; Parkinson’s Disease Therapeutics Conference October 30, 2017 New York city USA; 13th International Conference on Alzheimer’s & Parkinson’s Disorders, March 29-April 2 2017 Vienna, Austria; 5th World Parkinson Congress, June 4-7 2019 Kyoto; Comprehensive Review of Movement Disorders for the Clinical Practitioner, August 1-4, 2017 Colorado USA;19th International Conference on Parkinson’s Disease & Movement Disorders May 25-26 2017 London UK;; International Parkinson & Movement Disorder Society,  Northwest Parkinson’s Foundation, American Neurological AssociationWorld Parkinson Coalition, American Parkinson’s Disease Association

Track 10: Advanced therapies in Parkinson’s Disease

In cutting edge Parkinson's malady (PD), neurologists and patients confront an unpredictable choice for a propelled treatment. While picking a treatment, the best accessible proof ought to be joined with the expert's skill and the patient's inclinations. Objective: The target of this investigation was to investigate current basic leadership in cutting edge PD. Techniques: We led centre gathering exchanges and individual meetings with patients (N = 20) who had gotten profound cerebrum incitement, Levodopa-Carbidopa intestinal gel, or subcutaneous Apo morphine implantation, and with their guardians (N = 16).

Related Conferences:  Parkinson’s Congress | Parkinson’s Conferences | Parkinson’s Meetings | Neuroscience Conferences

7th Addiction Research Conference and Therapy, November 13-15, 2017 Las Vegas, USA; 5th Neurological Disorders Conference and Stroke Conference, November 13-14, 2017 London, UK; 10th Alzheimer’s Disease Congress and Dementia Congress, May 30-31, 2018 Osaka Japan; 11th Vascular Dementia Conference February 22-23, 2018 Paris, France;20th Neuroscience Conference and Neurochemistry Conference February 26-27, 2018 Berlin, Germany; Parkinson’s Disease Therapeutics Conference October 30, 2017 New York city USA; 13th International Conference on Alzheimer’s & Parkinson’s Disorders, March 29-April 2 2017 Vienna, Austria; 5th World Parkinson Congress, June 4-7 2019 Kyoto; Comprehensive Review of Movement Disorders for the Clinical Practitioner, August 1-4, 2017 Colorado USA;19th International Conference on Parkinson’s Disease & Movement Disorders May 25-26 2017 London UK;; International Parkinson & Movement Disorder Society,  Northwest Parkinson’s Foundation, American Neurological AssociationWorld Parkinson Coalition, American Parkinson’s Disease Association

Track 11: Movement Disorders

An utilitarian development issue implies that there is strange development or situating of part of the body because of the sensory system not working legitimately (but rather not because of a fundamental neurological sickness).

Related Conferences: Parkinson’s Congress | Parkinson’s Conferences | Parkinson’s Meeting | Neuroscience Conferences

7th Addiction Research Conference and Therapy, November 13-15, 2017 Las Vegas, USA; 5th Neurological Disorders Conference and Stroke Conference, November 13-14, 2017 London, UK; 10th Alzheimer’s Disease Congress and Dementia Congress, May 30-31, 2018 Osaka Japan; 11th Vascular Dementia Conference February 22-23, 2018 Paris, France;20th Neuroscience Conference and Neurochemistry Conference February 26-27, 2018 Berlin, Germany; Parkinson’s Disease Therapeutics Conference October 30, 2017 New York city USA; 13th International Conference on Alzheimer’s & Parkinson’s Disorders, March 29-April 2 2017 Vienna, Austria; 5th World Parkinson Congress, June 4-7 2019 Kyoto; Comprehensive Review of Movement Disorders for the Clinical Practitioner, August 1-4, 2017 Colorado USA;19th International Conference on Parkinson’s Disease & Movement Disorders May 25-26 2017 London UK;; International Parkinson & Movement Disorder Society,  Northwest Parkinson’s Foundation, American Neurological AssociationWorld Parkinson Coalition, American Parkinson’s Disease Association

Track 12: Movement Disorders risk factors

Development Disorder can influence anybody at any age; in any case, young men are more influenced than young ladies. Stereotypic development issue generally influences youngsters who have mental impediment or are experiencing neurological disarranges.

Related Conferences:  Parkinson’s Congress | Parkinson’s Conferences | Parkinson’s Meeting | Neuroscience Conferences

7th Addiction Research Conference and Therapy, November 13-15, 2017 Las Vegas, USA; 5th Neurological Disorders Conference and Stroke Conference, November 13-14, 2017 London, UK; 10th Alzheimer’s Disease Congress and Dementia Congress, May 30-31, 2018 Osaka Japan; 11th Vascular Dementia Conference February 22-23, 2018 Paris, France;20th Neuroscience Conference and Neurochemistry Conference February 26-27, 2018 Berlin, Germany; Parkinson’s Disease Therapeutics Conference October 30, 2017 New York city USA; 13th International Conference on Alzheimer’s & Parkinson’s Disorders, March 29-April 2 2017 Vienna, Austria; 5th World Parkinson Congress, June 4-7 2019 Kyoto; Comprehensive Review of Movement Disorders for the Clinical Practitioner, August 1-4, 2017 Colorado USA;19th International Conference on Parkinson’s Disease & Movement Disorders May 25-26 2017 London UK;; International Parkinson & Movement Disorder Society,  Northwest Parkinson’s Foundation, American Neurological AssociationWorld Parkinson Coalition, American Parkinson’s Disease Association.

About Conference


Parkinson’s congress-2018  invites all the participants from all over the world to attend the parkinsons congress-2018  conference entitled “4th Global Experts Meeting on Parkinson’s & Movement Disorders” during May 14-15, 2018 Singapore. This gathering is predominantly will focus the most recent and energizing developments in each range of Parkinson’s research, and it will offer an exceptional opportunity for specialists from all over  the world to meet, network, and distinguish with different scientific interactions.

Parkinson’s disease is a dynamic neurological disorder that influences how the individual moves, including how they talk and compose. This disease is caused by low dopamine levels. Various useful treatments, utilizing therapies (physiotherapy), surgery and medications have recognized neurological disorders and changes in the patient group. People with Parkinson’s disease also experience stiffness and they find abnormality in carrying out the movements as rapidly as before- this is known as bradykinesia.

The Parkinson’s disease market in US is expected to grow at a rate of 5.3% from sales of of $1.1 billion in 2012 to $1.3 billion in 2022. Approximately 1 million adults in Asia are suffering from Parkinson’s disease, from where 60,000 were diagnosed annually. An estimated of 30%-50% of PD patients mainly suffering from depression. United States is in the fourth position in considering the death of people due to Parkinson’s disease. African Americans have the highest death rate of 66.4% followed by whites of 64.6%, Hispanic with 55.4% and Asians with 50.8%. Parkinson’s disease strikes 50% more men than women. The economic burden of Parkinson’s disease on patients and their families in the Asia is about $9.4 billion.

Why to attend:

 It is our great pleasure to welcome you to the “4th Global Experts Meeting on Parkinson’s & Movement Disorders” during May 14-15, 2018 Singapore.

 The Conference will encourage new discoveries and research by providing a platform for reporting of unique and unusual cases which enhance understanding of disease process, its diagnosis, management and clinic-pathologic correlations. It will provide a podium for wide-ranging aspects of psychological, neurological, molecular, genetic and behavioral pathways underlying addiction, and will focus on novel therapies providing quality care for people with unhealthy alcohol, tobacco, or other drug use and addictive behaviors across a spectrum of clinical settings. It will comprise of opening Keynote lectures by the renowned researcher and noble members working in the field of Neourology disorders research and treatment followed by the special workshop and symposium sessions by eminent scholars and therapeutic members for all the three days of the conference.

Target audience: Neurologists, Psychiatrists, Psychologists, Neurosurgeon, Head of the department, Director, Industries, Delegates, Clinical, Community members, Professors, Researchers, Students, Scientists, Nurses.

  • Neurologists and Directors
  • Physicians
  • Neuroscientists
  • Specialists
  • Researchers
  • Professors
  • Industrial Experts
  • Neurosurgeons
  • Psychiatrist
  • Nutritional Scientists
  • Lecturers and Students from Academia in the study of Parkinson disease
  • Students from Academia in the research of Neurology and Neuroscience
  • Therapists

Market Analysis

Parkinson’s disease market is set to expand from $2.1 billion in 2014 to $3.2 billion by 2021, at a moderate Compound Annual Growth Rate (CAGR) of 5.7 percent, game-changing treatments will not be available for the foreseeable future, according to business intelligence provider GBI Research.

There are around 10 million individuals experiencing Parkinson's infection all around. Parkinson's, as far as its essence, has a higher recurrence in the created nations. In the United States (U.S.), around 60,000 new cases are determined to have Parkinson's, every year. Parkinson's malady is an idiopathic sickness happening because of obscure causes. By and by, just symptomatic medication medicines are accessible in the market. Additionally, these indications are analysed at later stages when the greater part of the dopamine creating cells have lost their capacity. This situation demonstrates a looming requirement for inventive medications.

The worldwide Parkinson's sickness showcase is divided on the premise of medication sort and topography. As per sedate sort, the market is portioned into, advertised and pipeline drugs. The showcased drugs are additionally divided into Levodopa, Dopamine agonists, Apomorphine, Glutamate rival, Anticholinergics, COMT inhibitors and MAO-B inhibitors. Topographically, the market is sectioned crosswise over four locales to be specific North America, Europe, Asia Pacific, and LAMEA.

The market for neurodegenerative confusion medicines can be separated into three portions: dynamic dementia, dynamic dementia with other neurological variations from the norm, and development issue.

Dynamic dementia medicines are relied upon to have an estimation of $7.3 billion out of 2012 and about $11 billion of every 2017, a CAGR of 8.4%.

Medicines for dynamic dementia with other neurological variations from the norm should add up to $537.2 million out of 2012 and $913.7 million out of 2017, a CAGR of 11.2%.

Medicines for development issue are relied upon to be worth $3.2 billion out of 2012 and $4.8 billion out of 2017, a CAGR of 8.3%.

In spite of energizing advances in the treatment of disorders of dementia and development issue amid the previous three years, a total therapeudic treatment or medication item has not been found to date. This is basically because of the diverse idea of the maladies and the way that the majority of their fundamental causes are as yet obscure or being contemplated. Various medication items are in the market; nonetheless, these medications are to a great extent for the symptomatic treatment of these sicknesses. Along these lines, there is an earnest requirement for medications for the neurodegenerative sicknesses influencing a huge number of individuals around the world.

Pick up a diagram of the present and future qualities of the worldwide markets for medicines for disorders of dementia and development issue

Breakdown incomes by neurodegenerative infection and essential clinical/neurotic component

Survey applications for medications and restorative advancements for disorders of dementia and development issue

Recognize the real players in the business destined to contend well now and into what's to come

Survey patent data pertinent to the business.

 UNIVERSITIES IN SINGAPORE

  • Nanyang Technological University
  • Singapore Management University
  • SIM University
  • Singapore Institute of Technology
  • GlobalNxt University
  • Curtin Singapore
  • James Cook University Singapore
  • University of New South Wales Asia
  • Johns Hopkins in Singapore

Hospitals in Singapore

  • Alexandra Hospital
  • Changi General Hospital
  • Ng Teng Fong General Hospital
  • National University Hospital
  • Khoo Teck Puat Hospital
  • Singapore General Hospital
  • Tan Tock Seng Hospital
  • KK Women's and Children's Hospital

Companies Associated with Neurology in Singapore are

  • Farrer Park Company
  • Gleneagles
  • National Neuroscience Institute Sing health
  • Singapore Neurology Sleep centre
  • Parkway Pantai
  • Singapore Medical Group
  • Grifols Singapore

Major Associations around the Globe

  •   Neuropathy Association
  • The brain & behavior research foundation
  • Alzheimer's Association
  • American Academy of Neurology
  • European Neurological Societies
  • World Federation of Neurology
  • Spanish Society of Neurology
  •  Major Neurological Associations in Italy
  • Hilarescere Foundation in Italy
  • Italian MS society in Italy  
  • Southern Clinical Neurological Society
  • ESNR European Society of Neuroradiology
  • Vision sciences society

Around 500 top universities globally working in the field of Neuroscience

  •  Dalhousie University
  • Leiden University- Neither land
  • Temple University USA
  • University Oklahoma
  •  Boston Coll USA
  • Florida International University
  • University California – Davis
  • University Sheffield
  • University Manchester
  • University of Nottingham
  • Cardiff University
  • University of Toronto – Canada
  • Hospitals Associated with Neuroscience Research

All around the globe there are 6000 hospitals working on Neurology

  • Some of them among them are:
  • Johns Hopkins Hospital
  • World Brain Center Hospital
  • Duke University Hospital
  • Edward Hospital
  • Munson Medical Center

 

Past Conference Report

Parkinsons 2017

Past Conference Report on Parkinson-2017

Conferenceseries LLC takes a great pride in announcing the commencement of 3rdInternational Conference on Parkinson’s disease and Movement Disorders-2017 during September 25-26, 2017 at Chicago, USA. Parkinson-2017 has received a benevolent response from all over the world. This has been conducted with the aim and the categorical intent of promoting the developments of new perceptions and ideas for exploring the high level of knowledge reached by scientific community on Parkinson’s and Disorders. The extremely illustrious conference hosted by Conferenceseries LLC was marked with the attendance of young and brilliant researchers, business delegates, Neurologists, Neurosurgeon, Neuroscientists and talented student communities.

Parkinson 2017 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various newfangled topics related to the field of Parkinson’s disease and Movement Disorders.

The conference was organized around the theme “Research Strategies, propelled advancements and developments in Parkinson’s disease”. The event implanted a firm relation of upcoming strategies in the field of Parkinson’s disease with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.

This conference brought together Leading World Parkinson’s Neurologists, Physicians, Neuroscientists, Specialists, Researchers, Professors, Industrial Experts, Neurosurgeons, Psychiatrist, Nutritional Scientists, Lecturers and Students from Academia in the study of Parkinson disease, Students from Academia in the research of Neurology and Neuroscience, Therapists in which many issues in Parkinson’s field were discussed in depth to provide up-to-date information to the world. On the other hand, the meeting provided an opportunity for an open and animated sharing of ideas and experiences.

The conference witnessed an amalgamation of peerless speakers, who enlightened the crowd with their enviable research knowledge and on various alluring topics related to the field of Parkinson’s disease.

The Keynote Session by:

Susan Scanland, Dementia Connection® LLC, USA

Srinivasan Avathvadi Venkatesan, DR.M.G.R.Medical University, India

Jayakumar Rajadas, Stanford University, USA

Rajendra D Badgaiyan, University of Richmond, USA,

John M Baumann, University of Louisville, USA,

Tyrone Genade, Northwestern College, USA

Also, the poster presentations was judged by John M Baumann, University of Louisville, USA

Conferenceseries LLC offers its heartfelt appreciation to all the Organizing Committee Members, Chairs and Co-chairs, Speakers, Students, Media Partners and Editorial Board Members of Journal of Alzheimer Disease & Parkinsonism, Journal of Neurosurgery and Journal of Neurology and Neuroscience who supported the conference in every aspect for the awe-inspiring exhibition at the venue.

We once again thank you all for the enormous exquisite response. This inspires us to continue organizing events and conferences for furthering the Clinical Research. Conferenceseries LLC therefore, is glad to announce its "5th International Conference on Parkinson’s Disease and Movement Disorders" which will be held during June 08-09, 2018 Baltimore, USA.

Mark your calendars for the upcoming extravaganza; we are hoping to see you soon at Baltimore!         


Past Reports  Proceedings  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date May 14-15, 2018

Speaker Opportunity

Supported By

Journal of Alzheimer’s Disease & Parkinsonism Journal of Depression and Anxiety Journal of Neurological Disorders

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner